Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $134B
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Quarter Return
+7.54%
1 Year Return
+51.86%
3 Year Return
+235.75%
5 Year Return
+330.72%
10 Year Return
+1,748.3%
AUM
$96B
AUM Growth
+$96B
Cap. Flow
-$1.44B
Cap. Flow %
-1.5%
Top 10 Hldgs %
36.39%
Holding
500
New
14
Increased
150
Reduced
125
Closed
12

Sector Composition

1 Healthcare 27.94%
2 Consumer Discretionary 24.47%
3 Technology 18.46%
4 Communication Services 10.28%
5 Financials 7.24%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BB icon
426
BlackBerry
BB
$2.28B
$7.94K ﹤0.01%
2,434
OM icon
427
Outset Medical
OM
$247M
$7.9K ﹤0.01%
306
SGMO icon
428
Sangamo Therapeutics
SGMO
$157M
$7.88K ﹤0.01%
2,510
MNTV
429
DELISTED
Momentive Global Inc. Common Stock
MNTV
$7.67K ﹤0.01%
1,095
AMD icon
430
Advanced Micro Devices
AMD
$263B
$7.64K ﹤0.01%
118
FGEN icon
431
FibroGen
FGEN
$47.8M
$7.48K ﹤0.01%
467
HI icon
432
Hillenbrand
HI
$1.79B
$7.25K ﹤0.01%
170
WSM icon
433
Williams-Sonoma
WSM
$22.9B
$7.24K ﹤0.01%
63
ZYXI icon
434
Zynex
ZYXI
$49.7M
$6.69K ﹤0.01%
481
FOLD icon
435
Amicus Therapeutics
FOLD
$2.34B
$6.57K ﹤0.01%
538
RIO icon
436
Rio Tinto
RIO
$101B
$6.55K ﹤0.01%
92
+32
+53% +$2.28K
NVRO
437
DELISTED
NEVRO CORP.
NVRO
$6.1K ﹤0.01%
154
CRH icon
438
CRH
CRH
$74.7B
$6.05K ﹤0.01%
152
+52
+52% +$2.07K
BLUE
439
DELISTED
bluebird bio
BLUE
$5.95K ﹤0.01%
860
SUMO
440
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$5.88K ﹤0.01%
726
MATV icon
441
Mativ Holdings
MATV
$687M
$5.54K ﹤0.01%
265
RARE icon
442
Ultragenyx Pharmaceutical
RARE
$2.89B
$5.33K ﹤0.01%
115
CERS icon
443
Cerus
CERS
$251M
$5.33K ﹤0.01%
1,459
CSTL icon
444
Castle Biosciences
CSTL
$696M
$5.3K ﹤0.01%
225
AGIO icon
445
Agios Pharmaceuticals
AGIO
$2.19B
$5.22K ﹤0.01%
186
ATEX icon
446
Anterix
ATEX
$445M
$5.21K ﹤0.01%
162
OXM icon
447
Oxford Industries
OXM
$658M
$5.13K ﹤0.01%
55
ACMR icon
448
ACM Research
ACMR
$1.81B
$5.09K ﹤0.01%
660
XPER icon
449
Xperi
XPER
$278M
$4.99K ﹤0.01%
+579
New +$4.99K
LASR icon
450
nLIGHT
LASR
$1.44B
$4.75K ﹤0.01%
468